Susan Weber 
Managed Markets Access: 5 Oncology Payment Trends Revealed: How To Stay Ahead Of Uncertainty
For years, managed-care organizations have tried to reduce drug costs through generic substitution, denials, ...
Managed Markets: Why Access Is No Longer Just About “Tier”
SURE, FORMULARY TIERS ARE IMPORTANT. But they are only part of the equation. By ...
The Robust Oral Oncolytic Pipeline
As new oral oncolytics enter the market, health plans will not only have more ...
